Myriad Genetics (MYGN) Announces Thomas P. Slavin, M.D., Named Chief Medical Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq slides to near one-month low as AI rout deepens
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.34 +0.19 (4.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.15 | 52 Week High | $45.34 | |||
| Open | $4.20 | 52 Week Low | $15.92 | |||
| Day High | $4.37 | P/E | 1.86 | |||
| Day Low | $4.11 | EPS | $2.33 | |||
| Volume | 231,098 | |||||
